审计生产者价格指数:来自处方药制剂的微观证据

Auditing the Producer Price Index: Micro Evidence From Prescription Pharmaceutical Preparations

Journal of Business & Economic Statistics · 1993
被引 24
人大 AABS 4

中文导读

使用1984-1989年美国四家制药公司的月度数据,比较BLS拉氏指数与Divisia指数在处方药价格增长上的差异,发现BLS指数增速高出50%,并探究其原因。

Abstract

From January 1984 through December 1989, the Bureau of Labor Statistics (BLS) price index for prescription pharmaceuticals grew at 9.09% per year. Using BLS-type Laspeyres index procedures with monthly price and quantity data on all prescription pharmaceuticals sold by four U.S. pharmaceutical manufacturers accounting for 24% of industry domestic sales, we find that the four-company index increases at 6.68% per year. When we employ a Divisia price index with smoothed weights incorporating new goods, the index grows 6.03% per year. Why does the BLS index grow 50% more rapidly than the Divisia index? That mystery is the focal point of our article.

生产者价格指数处方药价格指数偏差新产品